Medicine and Dentistry
Posttransplant Lymphoproliferative Disease
100%
Positron Emission Tomography-Computed Tomography
73%
Diagnosis
44%
Positron Emission Tomography
37%
Computer Assisted Tomography
31%
Fluorodeoxyglucose F 18
30%
Neoplasm
25%
Classical Hodgkin Lymphoma
17%
Lymphoproliferative Disease
16%
Epstein Barr Virus
16%
Diagnostic Performance
15%
Fluorine-18
14%
Systematic Review
14%
Necrosis
14%
Morphology
14%
Meta-Analysis
14%
Overall Survival
14%
Diffuse Large B-Cell Lymphoma
14%
Cell-Free DNA
14%
Positron Emission Tomography
14%
International Prognostic Index
14%
Pediatrics
14%
Molecular Imaging
14%
Follicular Lymphoma
14%
Radiomics
14%
Treatment Response
14%
Disease
14%
False Positive Result
9%
Transplantation
8%
Single Nucleotide Polymorphism
7%
False Negative Result
7%
Logistic Regression Analysis
7%
Biopsy
6%
Hematopoietic Stem Cell Transplantation
6%
Copy Number Variation
6%
Retrospective Study
6%
Serositis
5%
Epstein-Barr Virus
5%
Keyphrases
Post-transplant Lymphoproliferative Disorder
57%
18F-FDG PET-CT
28%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
28%
Cell-free DNA (cfDNA)
19%
Lymphoma
16%
PET-computed Tomography
14%
Overall Survival
14%
Morphological Variation
14%
Quantitative Characterization
14%
Volumetric Parameters
14%
Genomic Profiling
14%
Molecular Imaging
14%
International Prognostic Index
14%
Tumor
10%
Epstein-Barr Virus
10%
Copy number Variation
8%
Single nucleotide Variant
8%
18F-fluorodeoxyglucose (18F-FDG)
7%
Non-destructive
6%
Epstein-Barr Virus-positive
6%
Total Lesion Glycolysis
6%
Metabolic Tumor Volume
6%
